423 related articles for article (PubMed ID: 9188591)
1. Role for highly regulated rep gene expression in adeno-associated virus vector production.
Li J; Samulski RJ; Xiao X
J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
Shi S; Mercer SA; Dilley R; Trippel SB
Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
[TBL] [Abstract][Full Text] [Related]
4. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.
Vincent KA; Piraino ST; Wadsworth SC
J Virol; 1997 Mar; 71(3):1897-905. PubMed ID: 9032320
[TBL] [Abstract][Full Text] [Related]
5. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
Xiao X; Li J; Samulski RJ
J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
[TBL] [Abstract][Full Text] [Related]
6. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
7. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.
Philpott NJ; Giraud-Wali C; Dupuis C; Gomos J; Hamilton H; Berns KI; Falck-Pedersen E
J Virol; 2002 Jun; 76(11):5411-21. PubMed ID: 11991970
[TBL] [Abstract][Full Text] [Related]
8. The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production.
Ogasawara Y; Urabe M; Ozawa K
Microbiol Immunol; 1998; 42(3):177-85. PubMed ID: 9570283
[TBL] [Abstract][Full Text] [Related]
9. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.
Weger S; Wistuba A; Grimm D; Kleinschmidt JA
J Virol; 1997 Nov; 71(11):8437-47. PubMed ID: 9343200
[TBL] [Abstract][Full Text] [Related]
10. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
11. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
12. Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production.
Johari YB; Pohle TH; Whitehead J; Scarrott JM; Liu P; Mayer A; James DC
Biotechnol J; 2024 Jun; 19(6):e2300685. PubMed ID: 38900035
[TBL] [Abstract][Full Text] [Related]
13. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.
Hölscher C; Kleinschmidt JA; Bürkle A
J Virol; 1995 Nov; 69(11):6880-5. PubMed ID: 7474103
[TBL] [Abstract][Full Text] [Related]
14. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
16. Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.
Kyöstiö SR; Owens RA; Weitzman MD; Antoni BA; Chejanovsky N; Carter BJ
J Virol; 1994 May; 68(5):2947-57. PubMed ID: 8151765
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
18. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
19. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
